Structure-affinity relationships of halogenated predicentrine and glaucine derivatives at D1 and D2 dopaminergic receptors:: halogenation and D1 receptor selectivity

被引:35
作者
Asencio, M
Hurtado-Guzmán, C
López, JJ
Cassels, BK [1 ]
Protais, P
Chagraoui, A
机构
[1] Univ Chile, Fac Sci, Dept Chem, Santiago, Chile
[2] Univ Chile, Fac Sci, Millennium Inst Adv Studies Cell Biol & Biotechno, CBB, Santiago, Chile
[3] Univ Chile, Fac Med, ICBM, Programme Mol & Clin Pharmacol, Santiago 70000 7, Casilla, Chile
[4] Univ Rouen, Fac Med & Pharm, Physiol Lab, F-7600 Rouen, France
关键词
aporphines; halogenated predicentrines; halogenated glaucines; dopamine receptor affinities;
D O I
10.1016/j.bmc.2005.03.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Halogenation of the aporphine alkaloid boldine at the 3-position leads to increased affinity for rat brain D-1-like dopaminergic receptors with some selectivity over D-2-like receptors. A series of 3-halogenated and 3,8-dihalogenated (halogen = Cl, Br or 1) derivatives of predicentrine (9-O-methylboldine) and glaucine (2,9-di-O-methylboldine) were prepared and assayed for binding at D-1 and D-2 sites. Halogenation of predicentrine led to strong increases in affinity for D-1-like receptors, while the affinities for D-2-like receptors were either practically unchanged or reduced three- to fourfold. Halogenated glaucine derivatives did not show any clear trend towards enhanced selectivity, and the affinities were poor and similar to or worse than the values previously recorded for glaucine itself. Together with earlier work on boldine derivatives, these results suggest that the 2-hydroxy group on the aporphine skeleton may determine a binding mode favoring D-1-like over D-2-like receptors, with enhanced affinity when the C-3 position is halogenated. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3699 / 3704
页数:6
相关论文
共 39 条
[21]   Functional selectivity of dopamine receptor agonists.: II.: Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs [J].
Kilts, JD ;
Connery, HS ;
Arrington, EG ;
Lewis, MM ;
Lawler, CP ;
Oxford, GS ;
O'Malley, KL ;
Todd, RD ;
Blake, BL ;
Nichols, DE ;
Mailman, RB .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (03) :1179-1189
[22]   SPECIFIC INVITRO AND INVIVO BINDING OF H-3-RACLOPRIDE - A POTENT SUBSTITUTED BENZAMIDE DRUG WITH HIGH-AFFINITY FOR DOPAMINE D-2 RECEPTORS IN THE RAT-BRAIN [J].
KOHLER, C ;
HALL, H ;
OGREN, SO ;
GAWELL, L .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (13) :2251-2259
[23]   APORPHINES .15. ACTION OF APORPHINE ALKALOIDS ON DOPAMINERGIC MECHANISMS IN RAT-BRAIN [J].
MILLER, RJ ;
KELLY, PH ;
NEUMEYER, JL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 35 (01) :77-83
[24]   APORPHINES .48. ENANTIOSELECTIVITY OF (R)-(-)- AND (S)-(+)-N-NORMAL-PROPYLNORAPOMORPHINE ON DOPAMINE-RECEPTORS [J].
NEUMEYER, JL ;
REISCHIG, D ;
ARANA, GW ;
CAMPBELL, A ;
BALDESSARINI, RJ ;
KULA, NS ;
WATLING, KJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (04) :516-521
[25]  
NEUMEYER JL, 1983, DOPAMINE RECEPTOR AG, P11
[26]   SELECTIVE AND STEREOSPECIFIC INTERACTIONS OF R-SK-AND-F 38393 WITH [H-3]-LABELED PIFLUTIXOL BUT NOT [H-3]SPIPERONE BINDING TO STRIATAL D1-DOPAMINE AND D2-DOPAMINE RECEPTORS - COMPARISONS WITH SCH-23390 [J].
OBOYLE, KM ;
WADDINGTON, JL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 98 (3-4) :433-436
[27]   Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET [J].
Okubo, Y ;
Suhara, T ;
Suzuki, K ;
Kobayashi, K ;
Inoue, O ;
Terasaki, O ;
Someya, Y ;
Sassa, T ;
Sudo, Y ;
Matsushima, E ;
Iyo, M ;
Tateno, Y ;
Toru, M .
NATURE, 1997, 385 (6617) :634-636
[28]   Aberrant behavioral effects of a dopamine D1 receptor antagonist and agonist in monkeys: Evidence of uncharted dopamine D1 receptor actions [J].
Peacock, L ;
Gerlach, J .
BIOLOGICAL PSYCHIATRY, 2001, 50 (07) :501-509
[29]   APORPHINES AS ANTAGONISTS OF DOPAMINE D-1 RECEPTORS [J].
SCHAUS, JM ;
TITUS, RD ;
FOREMAN, MM ;
MASON, NR ;
TRUEX, LL .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (02) :600-607
[30]   BINDING OF [H-3] SCH23390 IN RAT-BRAIN - REGIONAL DISTRIBUTION AND EFFECTS OF ASSAY CONDITIONS AND GTP SUGGEST INTERACTIONS AT A D1-LIKE DOPAMINE RECEPTOR [J].
SCHULZ, DW ;
STANFORD, EJ ;
WYRICK, SW ;
MAILMAN, RB .
JOURNAL OF NEUROCHEMISTRY, 1985, 45 (05) :1601-1611